Literature DB >> 23463512

Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor β1 (TGF-β1) activation.

Teresa M Brophy1, Barry S Coller, Jasimuddin Ahamed.   

Abstract

TGF-β1 is a disulfide-bonded homodimeric protein produced by platelets and other cells that plays a role in many physiologic and pathologic processes. TGF-β1 is secreted as an inactive large latent complex (LLC) comprised of TGF-β1, latency-associated peptide, and latent TGF-β binding protein 1. We previously demonstrated that shear force can activate LLC and that thiol-disulfide exchange contributes to the process. We have now investigated the role of thiol isomerases in the activation of LLC in platelet releasates (PR) and recombinant LLC. The wasp venom peptide mastoparan, which inhibits the chaperone activity of PDI, inhibited stirring- and shear-induced activation of latent TGF-β1 by 90 and 75% respectively. To identify the proteins that bind to mastoparan either directly or indirectly, PR were chromatographed on a mastoparan affinity column. Latent TGF-β binding protein 1, latency-associated peptide, TGF-β1, clusterin, von Willebrand factor, multimerin-1, protein disulfide isomerase (PDI), ERp5, ERp57, and ERp72 eluted specifically from the column. Anti-PDI RL90 attenuated the inhibitory effect of mastoparan on LLC activation. Furthermore, reduced PDI inhibited activation of PR LLC, whereas oxidized PDI had no effect. We conclude that thiol isomerases and thiol-disulfide exchange contribute to TGF-β1 activation and identify a number of molecules that may participate in the process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463512      PMCID: PMC3624443          DOI: 10.1074/jbc.M112.439034

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  EMILIN-3, peculiar member of elastin microfibril interface-located protein (EMILIN) family, has distinct expression pattern, forms oligomeric assemblies, and serves as transforming growth factor β (TGF-β) antagonist.

Authors:  Alvise Schiavinato; Ann-Kathrin A Becker; Miriam Zanetti; Diana Corallo; Martina Milanetto; Dario Bizzotto; Giorgio Bressan; Marija Guljelmovic; Mats Paulsson; Raimund Wagener; Paola Braghetta; Paolo Bonaldo
Journal:  J Biol Chem       Date:  2012-02-10       Impact factor: 5.157

2.  Redox-dependent domain rearrangement of protein disulfide isomerase coupled with exposure of its substrate-binding hydrophobic surface.

Authors:  Olivier Serve; Yukiko Kamiya; Aya Maeno; Michiko Nakano; Chiho Murakami; Hiroaki Sasakawa; Yoshiki Yamaguchi; Takushi Harada; Eiji Kurimoto; Maho Yagi-Utsumi; Takeshi Iguchi; Kenji Inaba; Jun Kikuchi; Osamu Asami; Tsutomu Kajino; Toshihiko Oka; Masayoshi Nakasako; Koichi Kato
Journal:  J Mol Biol       Date:  2009-11-26       Impact factor: 5.469

3.  Latent TGF-β structure and activation.

Authors:  Minlong Shi; Jianghai Zhu; Rui Wang; Xing Chen; Lizhi Mi; Thomas Walz; Timothy A Springer
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

4.  Clusterin attenuates the development of renal fibrosis.

Authors:  Gwon-Soo Jung; Mi-Kyung Kim; Yun-A Jung; Hye-Soon Kim; In-Sun Park; Bon-Hong Min; Ki-Up Lee; Jung-Guk Kim; Keun-Gyu Park; In-Kyu Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

5.  The disulfide isomerase ERp57 mediates platelet aggregation, hemostasis, and thrombosis.

Authors:  Yi Wu; Syed S Ahmad; Junsong Zhou; Lu Wang; Matthew P Cully; David W Essex
Journal:  Blood       Date:  2011-12-29       Impact factor: 22.113

6.  Effect of protein disulfide isomerase chaperone activity inhibition on tissue factor activity.

Authors:  A Raturi; W Ruf
Journal:  J Thromb Haemost       Date:  2010-05-21       Impact factor: 5.824

7.  Human protein-disulfide isomerase is a redox-regulated chaperone activated by oxidation of domain a'.

Authors:  Chao Wang; Jiang Yu; Lin Huo; Lei Wang; Wei Feng; Chih-chen Wang
Journal:  J Biol Chem       Date:  2011-11-16       Impact factor: 5.157

8.  Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.

Authors:  A E G Lenferink; C Cantin; A Nantel; E Wang; Y Durocher; M Banville; B Paul-Roc; A Marcil; M R Wilson; M D O'Connor-McCourt
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

9.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

Authors:  Myriam Labelle; Shahinoor Begum; Richard O Hynes
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

10.  Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload.

Authors:  Alexander Meyer; Wei Wang; Jiaxiang Qu; Lori Croft; Jay L Degen; Barry S Coller; Jasimuddin Ahamed
Journal:  Blood       Date:  2011-12-01       Impact factor: 25.476

View more
  12 in total

Review 1.  Vascular thiol isomerases.

Authors:  Robert Flaumenhaft; Bruce Furie
Journal:  Blood       Date:  2016-06-29       Impact factor: 22.113

Review 2.  Control of blood proteins by functional disulfide bonds.

Authors:  Diego Butera; Kristina M Cook; Joyce Chiu; Jason W H Wong; Philip J Hogg
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

3.  Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Authors:  George S Laszlo; Todd A Alonzo; Chelsea J Gudgeon; Kimberly H Harrington; Robert B Gerbing; Yi-Cheng Wang; Rhonda E Ries; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Roland B Walter
Journal:  Clin Cancer Res       Date:  2015-03-30       Impact factor: 12.531

Review 4.  Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins.

Authors:  Ian B Robertson; Daniel B Rifkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

5.  Association between shear stress and platelet-derived transforming growth factor-β1 release and activation in animal models of aortic valve stenosis.

Authors:  Wei Wang; Spandana Vootukuri; Alexander Meyer; Jasimuddin Ahamed; Barry S Coller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-05       Impact factor: 8.311

6.  A single nucleotide polymorphism in the TGF-β1 gene (rs1982073 C>T) may contribute to increased risks of bone fracture, osteoporosis, and osteoarthritis: a meta-analysis.

Authors:  Yu Cong; Jiang-Ying Ru; Ni-Rong Bao; Ting Guo; Jian-Ning Zhao
Journal:  Clin Rheumatol       Date:  2014-12-13       Impact factor: 2.980

Review 7.  Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation.

Authors:  Ian B Robertson; Daniel B Rifkin
Journal:  Cytokine Growth Factor Rev       Date:  2013-07-12       Impact factor: 7.638

8.  Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury.

Authors:  Shahrouz Ghafoory; Rohan Varshney; Tyler Robison; Karim Kouzbari; Sean Woolington; Brennah Murphy; Lijun Xia; Jasimuddin Ahamed
Journal:  Blood Adv       Date:  2018-03-13

9.  Dysregulation of the Transforming Growth Factor β Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia.

Authors:  Jingping Ge; Marisa Apicella; Jason A Mills; Loïc Garçon; Deborah L French; Mitchell J Weiss; Monica Bessler; Philip J Mason
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

10.  A substrate-driven allosteric switch that enhances PDI catalytic activity.

Authors:  Roelof H Bekendam; Pavan K Bendapudi; Lin Lin; Partha P Nag; Jun Pu; Daniel R Kennedy; Alexandra Feldenzer; Joyce Chiu; Kristina M Cook; Bruce Furie; Mingdong Huang; Philip J Hogg; Robert Flaumenhaft
Journal:  Nat Commun       Date:  2016-08-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.